Chief Physician, Expert of the International Department, MD, PI. Graduated from Central South University, and received professional and systematic training in radiotherapy at well-known domestic oncology hospitals in Chengdu, Beijing, and Guangzhou.
Haiba News A mother lived with a "tumor" in her neck for 52 years, her trachea nearly completely blocked! Just when all seemed lost, dedicated doctors stepped up to meet the challenge
hinews.cn Liver cancer "Yttrium-90 treatment" has been in Hainan for five years now, and the first patient in China to get it is doing great—their condition's been stable long-term
Hainan Daily Experts at Hainan Cancer Hospital collaborated across multiple disciplines to perform surgery, successfully removing a tumor that had been hidden in a patient's neck for 52 years
Hainan Daily Five years without recurrence! Hainan's first advanced liver cancer patient treated with Yttrium-90 returns to a normal life
People's Daily Online Multidisciplinary Consultation Enables High-Difficulty Surgery—Hainan Provincial Tumor Hospital Removes 52-Year-Old Neck Tumor from 78-Year-Old Patient
www.ehnjk.com First Hainan patient treated with Yttrium-90 for liver cancer remains recurrence-free after five years of follow-up
China News Service From "First Case" to "Hundreds of Cases"—Hainan Doctors Advance Precision Radiotherapy for Liver Cancer Nationwide
Haiba News Liver cancer "Yttrium-90 treatment" has been in Hainan for five years now, and the first patient in China to get it is doing great—their condition's been stable long-term
Consumer Daily Five years since it landed in Hainan! The first domestic patient treated with yttrium-90 for liver cancer has achieved long-term stable condition
Consumption Daily Hainan Medical University Affiliated Cancer Hospital and Hainan Chengmei Hospital Partner with China Pacific Insurance to Implement Multiple New Medical-Insurance Convenience Measures
Chief Physician
Specializes in head and neck tumors (including brain/nasopharynx/oropharynx/hypopharynx/larynx/parotid gland/sinus/esophagus, etc.); breast cancer; digestive system tumors (including liver cancer/pancreas/stomach/rectum/pancreatic head/gallbladder cancer, etc.); urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, kidney cancer); radiation therapy for pediatric tumors, soft tissue sarcomas, chest tumors, and rare tumors; skilled in integrating multi-modal advanced radiotherapy techniques to treat difficult and complex intractable tumors; experienced in the prevention, diagnosis, and treatment of complications from tumor chemoradiotherapy.
Chief Physician, Expert of the International Department, MD, PI. Graduated from Central South University, and received professional and systematic training in radiotherapy at well-known domestic oncology hospitals in Chengdu, Beijing, and Guangzhou.
Specialties: Head and neck tumors (including brain, nasopharynx, oropharynx, hypopharynx, larynx, parotid gland, sinuses, esophagus, etc.); breast cancer; digestive system tumors (including liver cancer, pancreatic cancer, gastric cancer, rectal cancer, pancreatic head cancer, gallbladder cancer, etc.); urogenital tumors (including cervical cancer, prostate cancer, endometrial cancer, kidney cancer); radiation therapy for pediatric tumors, soft tissue sarcomas, chest tumors, and rare tumors; integration of multimodal advanced radiotherapy techniques for the treatment of difficult and complex intractable tumors; extensive experience in the prevention, diagnosis, and treatment of complications from tumor chemoradiotherapy.
The mechanism of occurrence and development of malignant tumors, as well as the radioimmunotherapy for complex and refractory tumors such as recurrence and metastasis (including spatial fractionation radiotherapy, low-dose radiotherapy, targeted radiotherapy with draining lymph node preservation, simultaneous boost stereotactic radiotherapy, three-dimensional brachytherapy, etc.).
I. Member of the Second Committee of the Palliative Care Specialty Committee of the Chinese Anti-Cancer Association
II. Member of the Third Committee of the Radiotherapy Equipment Technology Branch of the China Medical Equipment Association
III. Standing Committee Member of the Seventh Committee of the Radiation Oncology Branch of the Hainan Provincial Medical Association
IV. Member of the Lung Cancer Professional Committee of the Hainan Provincial Cancer Prevention and Control Association
V. Vice Chairman of the Multidisciplinary Treatment (MDT) Professional Committee of the Hainan Provincial Cancer Prevention and Treatment Association
VI. Executive member of the Fertility Preservation Professional Committee of the Hainan Provincial Maternal and Child Health Care Association
VII. Member of the First Committee of the Integrative Rehabilitation Specialty for Nasopharyngeal Cancer, Chinese Anti-Cancer Association
VIII. Member of the Expert Committee for the Special Skills Training Program in Precision Radiotherapy for Tumors (in the direction of target delineation) at the Talent Exchange Service Center of the National Health Commission
IX. Member of the Expert Committee of the Medical Quality Control Center for Radiotherapy Specialty in Hainan Province (June 2023 - December 2024)
I. Proteomics analysis of G protein-coupled receptor kinase 4-inhibited cellular growth of HEK293 cells. J Proteomics. 2019; 207:103445.
II. The role of radiotherapy for pancreatic malignancies: a population-based analysis of the SEER database, Clin Transl Oncol, 2021,7.
III. Role of CD5L and SRD5A2 as Prognostic Biomarkers for Hepatocellular Carcinoma, Int J Gen Med, 2021, 14: 9247-9260.
IV. Myoepithelial carcinoma of major salivary glands: Analysis of population-based clinicopathologic and prognostic features, Translational oncology 20 (2022) 101410.